This is a summary of the European public assessment report (EPAR) for Neofordex. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Neofordex. For practical information about using Neofordex, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
Treatment of multiple myeloma.
Therapeutic Area (MeSH)
ATC Code
H02AB02
ATC Item
N/A
Pharmacotherapeutic Group
Corticosteroids for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Neofordex
Medicine Name
Neofordex
Aliases
N/ANo risk management plan link.
